The company's subscribers may place a higher value on TV series, which are more conducive to 'binge viewing' and are superior at engaging a fan base.
Investors adore the business leaders on this list. They've accomplished an amazing feat.
The classification of ibrutinib as a breakthrough therapy could mean speedy approval by the agency.
Pomalyst for multiple myeloma is a potentially big and important new treatment for the company.
US deficits, global currency debasement and recent market action suggest the precious metals could be poised for a breakout.
Long-established dot.com's and game makers are breaking new ground, and Internet security is an increasing concern.
The month also features a big gathering of biotech CEOs in New York and a cancer research meeting in Florida.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Plus, after much ado, Softbank is oh-so-close to acquiring Sprint.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Those shackled with student loan debt are increasingly being targeted by scams and shady companies promising relief.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.